Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabitril in Generalized Anxiety Disorder
NCT00236015Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tiagabine in generalized anxiety disorder (GAD), sponsored by Cephalon, Inc.. Started Nov 2004; status: completed.
02
Drugs
tiagabine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00236015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236015.